Search
Search
Share
Share
Facebook
Twitter
LinkedIn
Mail
Location
Location
North America
Europe
Asia
Idorsia is expanding its global footprint to reach more patients with our transformative treatments.
We conduct research, clinical development and commercial operations out of the following locations. Click the pin to find out more.
Click the arrows to navigate across geographies.
Click the pin to find out more.
Austria
Allschwil,
Switzerland
Berlin, Germany
Cherry Hill, New Jersey, USA
Lörrach,
Germany
London,
UK
Madrid, Spain
Montreal, Canada
Munich,
Germany
Paris, France
Radnor,
Pennsylvania,
USA
Stockholm,
Sweden
Milan, Italy
Shanghai, China
Cherry Hill, New Jersey, USA
Montreal, Canada
Radnor, Pennsylvania, USA
Austria
Allschwil, Switzerland
Berlin, Germany
Lörrach, Germany
London, UK
Madrid, Spain
Munich, Germany
Paris, France
Stockholm, Sweden
Milan, Italy
Shanghai, China
Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil
Switzerland
Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil
Switzerland
Headquarters of Idorsia Ltd.
Responsible for drug discovery, development, registration, production, quality assurance, safety, as well as company management and coordination.
Idorsia (Berlin) Pharmaceuticals GmbH
Magnusstrasse 11
D-12489 Berlin
Germany
A 100% subsidiary of Idorsia Pharmaceuticals Ltd, based in Berlin, Germany
– discovers and develops synthetic carbohydrate vaccines to prevent infection.
Idorsia Clinical Development US Inc.
1820 Chapel Avenue West Suite
150 Cherry Hill, NJ 08002
United States
Based in New Jersey, US
– performs clinical development on behalf of Idorsia.
Idorsia Pharmaceuticals Deutschland GmbH
Marie-Curie-Strasse 8
DE-79539 Lörrach
Germany
A 100% subsidiary of Idorsia Ltd, based in Lörrach, Germany
– performs clinical development on behalf of the Group and acts as Idorsia’s representative for obtaining regulatory approvals in the EU.
Idorsia Pharmaceuticals UK Limited
20 Eastbourne Terrace London,
W2 6LG
United Kingdom
A 100% subsidiary of Idorsia Ltd, based in London, United Kingdom
– is responsible for the Group’s marketing operations in the United Kingdom.
Idorsia Pharmaceuticals Spain S.L.
Paseo Castellana 79
ES-28046 Madrid
Spain
A 100% subsidiary of Idorsia Ltd, based in Madrid, Spain
– is responsible for the Group’s marketing in Spain.
Idorsia Pharmaceuticals Canada Ltd.
220-6500 RTE Transcanadienne
Pointe Claire, Quebec
H9R0A5
Canada
Based in Montreal, Canada
– responsible for the Idorsia’s commercial operations in Canada.
Idorsia Pharmaceuticals Germany GmbH
Dachauerstr. 63
80335 München
Germany
A 100% subsidiary of Idorsia Ltd, based in Munich, Germany
– is responsible for the Group’s marketing operations in Germany.
Idorsia Pharmaceuticals France SAS
Immeuble Colisée Gardens -
Bâtiment B
8-14 Avenue de l'Arche
FR-92400 Courbevoie
France
A 100% subsidiary of Idorsia Ltd, based in Paris, France
– will be responsible for the Group’s marketing operations in France.
Idorsia Pharmaceuticals US Inc.
One Radnor Corporate Center, Suite 101
100 Matsonford Rd
Radnor, PA 19087
United States
Based in Radnor, Pennsylvania, US
– is responsible for the commercial operations in the US.
Idorsia Pharmaceuticals Nordics AB
c/o FirstOffice
Gustav III's Boulevard 46
69 73 Solna
Sweden
A 100% subsidiary of Idorsia Ltd, based in Stockholm, Sweden
– responsible for the Idorsia’s commercial operations in Sweden, Norway, Finland, and Denmark.
Idorsia Pharmaceuticals Italy S.r.l.
Via Fabio Filzi 25A
20124 Milan
Italy
Idorsia (Shanghai) Pharmaceuticals Co., Ltd
Room 311, No. 6, Lane 368
Lushuo Road
Shanghai
China
Based in Shanghai, PRC
– performs research and development on behalf of Idorsia.
Contact
Contact
For patients and healthcare professionals
General Contact
Data Protection Officer
Whistleblower Hotline
Whistleblower Hotline:
+41 58 844 0106
Webmaster
Toggle navigation
Home
About Us
About Us
Overview
Responsibilities
People
Research & Development
Target diseases
Target diseases
Overview
Insomnia